Hello, my name is Mangesh Kritya. I am an IMG from Armed Forces Medical College 🇮🇳 and a Postdoctoral Research Fellow at @HMethodistCV I am applying for Internal Medicine Residency - Match 2026 AAMC ID: 16589828 #MedTwitter #Match2026 #InternalMedicine

Just wrapped up 4 incredible days at #TCT2025! Had the chance to present our work, reconnect with old friends, meet inspiring new people, and experience truly groundbreaking science. Grateful for this amazing 🫀community. @TCTMD @crfheart @MethodistHosp

TCT Day 4: From HMH TAVR registry 👉🏽 Long term outcomes in SEV vs BEV in small aortic Annuli ✅ No difference in Mortality, HFH & BVF (Median f/u: 743 days) 👉🏽 Long term impact of new LBBB post TAVR ✅ No impact on mortality ❗️High rate of PPM placement @SachinGoelMD #TCT2025

TCT Day 3: Presented our case on Emergent Snorkel Stenting for LM Occlusion following ViV TAVR. 👉🏽 Key Takeaway: During BVF/BVR, VTCs may underestimate the risk of coronary obstruction in bioprosthetic valves with externally mounted leaflets. @SachinGoelMD #TCT2025 #MedTwitter

TCT 2025 Day 2: Presented 2 abstracts 👉🏽 Sex-based differences post IV brachytherapy for ISR ❗️High TLR in women 👉🏽 Procedural success rate in CTO PCI in small versus large vessels ❗️Low procedural success rates in small vessels @AlpeshShahMD @KharsaChloe #MedTwitter #TCT2025

TCT 2025 Day 1: Three generations of Armed Forces Medical College 🇮🇳 @dhall_dr @ShariqShamimMD @crfheart #TCT2025 #MedTwitter #cardiotwitter

Very important topic. I had the pleasure of writing the associated editorial with the amazing @AGoldsweig We summarized all modalities currently used to assess graft patency post CABG. Link:

❗️New Publication❗️ Check out our article in the @AmJCardio on the Obesity paradox in CTO PCI from the Houston Methodist CTO PCI registry.

Very happy to present our Houston Methodist work at the upcoming @crfheart #TCT2025. Thank you for the opportunity.

Key takeaway from EARLY TAVR, presented by @PhilGenereuxMD at #14thAnnualMMICVI @MethodistHosp ⏰ Don’t wait for symptoms! ✅ Refer early ✅ Complete the AS workup ✅ Treat within 3 months of symptom onset Early TAVR = fewer complications + $$$ saved

🚨New manuscript just published!! In 199 patients with ISR treated by IVB: ✔️82% free of TLR at 1y ⚠️ Non responders had ⬆️ MI, thrombosis, mortality ❗️Stent use: ⬆️ 3y mortality Full text: https://t.co/RqsjTPLbcQ @AlpeshShahMD @AndrewFarach @KrityaMangesh

Full manuscript link: https://t.co/U8L2krGS9v #cardiotwitter #MedTwitter #MedX

🔴New Publication🔴 🫀Does CKD affect brachytherapy outcomes in ISR? ☢️ 227 pts (54 CKD) 1-yr MACE: 63% (CKD) vs 33% 🎯 TLR: 31.5% vs 18% 🩸 Bleeding: CKD only (5.6%) ♂️ Within CKD: male sex ↓ TLR (HR 0.15) Full text link below👇 @AlpeshShahMD @AndrewFarach @HMethodistCV

Just out🚨 Our Houston Methodist CTO PCI Registry (507 pts, 2018-2023) shows CTO PCI is safe, effective and improving over time. ☑️ 81% success ☑️ 0.4% in-hospital mortality ☑️ 91% 2y OS @AlpeshShahMD 🔗 https://t.co/sxf1NkoyRV

Full Text link 👇 https://t.co/taHlzSGyEm https://t.co/jJxDW557Ww

🔴New Publication🔴 How does Tricuspid TEER compare with GDMT in patients with severe TR? ✅ ↓ Mortality ✅ ↓ HF hospitalizations ✅ Improved TR severity & NYHA class ❌ No excess stroke or PPM risk Check out the paper⬇️ @SachinGoelMD @HMethodistCV #cardiotwitter #MedX

New manuscript alert‼️ 💡Does cutting/scoring balloon prep improve outcomes vs. plain balloon before IVBT for ISR? 📊No difference in 1y outcomes ⚠️Outcomes appear to be influenced by lesion-specific factors. 🔗 https://t.co/BvFOCw4rK3 @MyJSCAI @AlpeshShahMD @AndrewFarach

Our abstract got accepted for moderated digital poster presentation at #AHA2025 conference. Many thanks to the co-authors especially @Priyanshi_Maury and @lshanmukh05 for their hard work. @American_Heart #AHA #MedX

Happy to have our presentation from the Houston Methodist TAVR registry listed among TAVR updates for July by @TCTMD Many thanks to the mentorship of Dr. @SachinGoelMD @HMethodistCV

Check out our latest work! @Taha_Hatab1 thank you so much for including me.